Blog December 2, 2020
FDA Issues Final Guidance Documents on Medical Device Data Systems and Mobile Medical Applications
- Person title
On Friday, February 6, 2015 the FDA posted a final guidance document on medical device data systems (MDDS). This confirms the FDA's position that due to the low risk these devices pose to patients and their importance in advancing digital health, it does not intend to enforce compliance with the regulatory controls that otherwise would apply. The finalization of this policy should inspire the development of new technologies to better use and display this data.
In addition, the FDA updated its Mobile Medical Apps guidance to be consistent with the final MDDS guidance.
The FDA is hosting a webinar on February 24, 2015 to discuss the final guidance documents and two draft guidances released in January on low risk products intended for general wellness and medical device accessories.
The opinions expressed are those of the authors on the date noted above and do not necessarily reflect the views of Fish & Richardson P.C., any other of its lawyers, its clients, or any of its or their respective affiliates. This post is for general information purposes only and is not intended to be and should not be taken as legal advice. No attorney-client relationship is formed.
Blog December 9, 2019
Blog July 26, 2019
Heightened Scrutiny of Specimens of Use at U.S. Trademark Office
Blog July 3, 2019
Legal Alert: New Rule Requires Foreign-Domiciled Trademark Applicants, Registrants, and Parties at TTAB to Be Represented by U.S. Attorney
Blog April 2, 2018
USPTO Pilot Program Regarding Specimen Authenticity
Blog July 5, 2017
U.S. Trademark Office Clarifies Filing Deadlines for Resurrecting Dead Applications and Registrations
Blog June 8, 2017
Even GOOGLE Can Google After All
Blog May 19, 2017
What Does The "In" in "Incontestable" Mean?
Blog February 7, 2017
U.S. Trademark Office Sharpens Machete for Pruning Deadwood
Blog February 3, 2017
FDA Final Guidance on Nonproprietary Names of Biological Products
Article March 16, 2023
Attorneys Kristen McCallion and Darra Loganzo Co-Author World Trademark Review Article "Could AI Require Platforms to Do More to Prevent Infringement?"
Article March 8, 2023
Senior Principal Terry Mahn Authors Medical Device + Diagnostic Industry Article "This Company's False Compliance With CISPR 11 Resulted in a $12 Million FCA...
Article February 17, 2023
Principals Patrick Darno and Peter Fasse Author "Patent Strategies for Protecting Bioinformatics Inventions" for IAM
Article February 3, 2023
Fish & Richardson Attorneys Author IAM Article "Neglect Begets Opportunity in Femtech IP"
Blog January 17, 2023
Biosimilars 2022 Year in Review
Article October 20, 2022
Life Sciences Entrepreneur Sourcebook | Intellectual Property: What It Is and Why You Should Care
Blog September 15, 2022
Legal Alert: What to Know About the USPTO's Duty of Candor Guidance Regarding FDA Submissions
Blog January 11, 2022
Biosimilars 2021 Year in Review
Article July 23, 2021
Fish Principal Cindy Walden Authors World IP Review Article "Brand Owner's Friend: the Lanham Act at 75"
Blog December 2, 2020